Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanwa Kagaku Kenkyusho Co., Ltd.

Latest From Sanwa Kagaku Kenkyusho Co., Ltd.

Amneal Adds Xolair Rival To Biosimilars Pipeline

Amneal has revealed the latest addition to its biosimilars pipeline, in the form of an omalizumab rival to Xolair developed by Kashiv Biosciences.

Biosimilars Deals

Naloxone Firms Commit To Boost Capacities In White House Opioid Overdose Epidemic Meeting

Emergent BioSolutions, Harm Reduction Therapetuics, Hikma, Teva and other drug manufacturers commit to increased supply of naloxone and nalmefene in meeting with ]White House Office of National Drug Control.

Prescription To OTC Switch Politics

US Court Sides With Amneal On ProAir Patents As Teva Vows Appeal

The inhaler patent saga goes on. A US District Court orders Teva to either de-list or correct patents for its inhaler ProAir HFA, but the originator disagrees and gets ready to appeal.

Legal Issues Generic Drugs

Amneal Launches Six Injectables With Some To Aid US Drug Shortage

Amneal aims to address the ongoing drug shortage crisis in the US with injectable additions to its portfolio. Meanwhile, the FDA states that it has “made a significant impact” to mitigate shortages, preventing 236 shortages in 2023.

Generic Drugs Market Access
See All

Company Information

  • Industry
  • Biotechnology
  • Distributors
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Nutraceuticals
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products